NASDAQ:VWR

(VWR) (VWR) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$33.24
$33.26
50-Day Range
N/A
52-Week Range
$24.42
$37.25
Volume
2.80 million shs
Average Volume
983,321 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
VWR stock logo

About (VWR) Stock (NASDAQ:VWR)

VWR Corporation is a provider of product and service solutions to laboratory and production customers. The Company offers a portfolio of branded and private label laboratory products, services and solutions to the life science, general research and applied markets. The Company operates in two segments: Americas and EMEA-APAC. The Americas segment consists of operations located principally in the United States and Canada, as well as in Puerto Rico, Mexico and select countries in Central and South America, including Costa Rica, Brazil, Argentina and Chile. As of December 31, 2016, the Americas segment included 67 facilities located in eight countries. As of December 31, 2016, the EMEA-APAC segment consisted of its operations located principally in Europe, as well as in certain Asia-Pacific countries, and included 110 facilities located in 26 countries. The Company's portfolio includes chemicals, reagents, consumables, durable products and scientific equipment and instruments.

VWR Stock News Headlines

Shankland named in PFA team of the year
These AI trades triggered this morning (545% return)
If you think a market crash is possible in 2024, I don't know why you're not using this yet.
Massive breakthrough for options traders.
A 34 year old man from central florida has uncovered a totally new way to trade options… Already this year it’s allowed real people to capture top returns of 50%... 100%... Even 200% overnight… Without using technical patterns, momentum, A.I. or any of the other commonly used strategies… Now, it’s important to mention that nothing is 100% perfect in terms of trading.
Singing Machine Co Inc MICS
GeminiBio Appoints Mike Guerra to its Board of Directors
St Mirren 2-0 Dundee: Analysis
Nick Pope set to return for Newcastle in March
See More Headlines
Receive VWR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (VWR) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/07/2017
Today
4/28/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:VWR
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Gregory L. Cowan CPA (Age 63)
    Chief Financial Officer, Senior Vice President
  • Gerard J. Christian (Age 48)
    Senior Vice President, Chief Global Business Services Officer
  • Nils Clausnitzer (Age 47)
    Senior Vice President, President - EMEA-APAC Lab Business
  • Ulf Kepper (Age 51)
    Senior Vice President - VWR Services
  • Mark T. McLoughlin (Age 61)
    Senior Vice President, President - U.S. Lab and Distribution Services
  • Douglas J. Pitts (Age 58)
    Vice President, Corporate Controller
  • George Van Kula (Age 53)
    Senior Vice President - Human Resources, General Counsel, Secretary
  • Harry M. Jansen Kraemer Jr. (Age 62)
    Chairman of the Board
  • Manuel A. Brocke-benz (Age 58)
    President, Chief Executive Officer, Director
  • Nicholas W. Alexos CPA (Age 53)
    Independent Director

VWR Stock Analysis - Frequently Asked Questions

How were (VWR)'s earnings last quarter?

(VWR) (NASDAQ:VWR) posted its quarterly earnings data on Tuesday, November, 7th. The medical research company reported $0.54 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.46 by $0.08. The medical research company earned $1.20 billion during the quarter, compared to analysts' expectations of $1.16 billion. The business's quarterly revenue was up 5.2% compared to the same quarter last year. During the same period in the previous year, the business posted $0.44 EPS.

What other stocks do shareholders of (VWR) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (VWR) investors own include Tesla (TSLA), Twitter (TWTR), United Airlines (UAL), Activision Blizzard (ATVI), BE Aerospace (BEAV), Sothebys (BID), Salesforce (CRM), Walt Disney (DIS), Direxion Daily Gold Miners Index Bear 2x Shares (DUST) and FOX (FOX).

This page (NASDAQ:VWR) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners